The Emerging Sarcopenia Treatment Market is driven by Increasing Geriatric Population
The sarcopenia treatment market involves the treatment of sarcopenia, which is the gradual loss of skeletal muscle mass and strength associated with aging. Some of the key therapies for sarcopenia treatment include protein supplementation, vitamin D and calcium supplementation, hormone replacement therapy, and exercise. The global sarcopenia treatment market has gained significant importance in recent years owing to the growing geriatric population suffering from age-related muscle loss. Protein supplementation products dominate the market and help in increasing muscle protein synthesis to combat muscle loss.
The Global sarcopenia treatment market is estimated to be valued at US$ 28.19 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the sarcopenia treatment market are Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd., Surfix B.V, GE Healthcare, F. Hoffmann-La Roche Ltd, and AYOXXA Biosystems GmbH. These players are focusing on developing innovative therapeutic agents and diagnostic tools for early detection and treatment monitoring of sarcopenia.
The growing geriatric population globally is leading to increased incidences of sarcopenia and age-related muscle weakness. This is driving significant demand for sarcopenia treatment products. Furthermore, increasing consumer awareness about the negative health impacts of muscle loss is also a key factor boosting the market growth.
Sarcopenia Treatment Market Trends is witnessing expanding operations of key players in emerging markets of Asia Pacific, Middle East, and Latin America. This is attributed to high growth potential offered by the large untapped patient base suffering from sarcopenia in these regions. Favorable government support and improving access to healthcare is further propelling the sarcopenia treatment uptake in these developing markets.
Get More Insight On- Sarcopenia Treatment Market
Explore More Related Article On- Lactulose Market
#growth , #trends , #market ,
The sarcopenia treatment market involves the treatment of sarcopenia, which is the gradual loss of skeletal muscle mass and strength associated with aging. Some of the key therapies for sarcopenia treatment include protein supplementation, vitamin D and calcium supplementation, hormone replacement therapy, and exercise. The global sarcopenia treatment market has gained significant importance in recent years owing to the growing geriatric population suffering from age-related muscle loss. Protein supplementation products dominate the market and help in increasing muscle protein synthesis to combat muscle loss.
The Global sarcopenia treatment market is estimated to be valued at US$ 28.19 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the sarcopenia treatment market are Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd., Surfix B.V, GE Healthcare, F. Hoffmann-La Roche Ltd, and AYOXXA Biosystems GmbH. These players are focusing on developing innovative therapeutic agents and diagnostic tools for early detection and treatment monitoring of sarcopenia.
The growing geriatric population globally is leading to increased incidences of sarcopenia and age-related muscle weakness. This is driving significant demand for sarcopenia treatment products. Furthermore, increasing consumer awareness about the negative health impacts of muscle loss is also a key factor boosting the market growth.
Sarcopenia Treatment Market Trends is witnessing expanding operations of key players in emerging markets of Asia Pacific, Middle East, and Latin America. This is attributed to high growth potential offered by the large untapped patient base suffering from sarcopenia in these regions. Favorable government support and improving access to healthcare is further propelling the sarcopenia treatment uptake in these developing markets.
Get More Insight On- Sarcopenia Treatment Market
Explore More Related Article On- Lactulose Market
#growth , #trends , #market ,
6 hours ago
